LIMINAL BIOSCIENCES INC (LMNL)

CA53272L2021 - Common Stock

8.5  +0.01 (+0.12%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-6-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
492.00K401.00K643.00K3.32M4.90M
Minority Interest Expense
-975.00K-122.00K669.00K830.00K1.04M
Cost Of Goods
N/AN/AN/A2.03M2.76M
Gross Profit
N/AN/AN/A1.28M2.14M
Operating Expenses
32.30M33.31M51.32M95.38M120.40M
Research and Development
15.62M15.43M18.98M56.83M75.11M
Selling, General, and Administrative Expenses
16.67M17.88M32.34M38.55M45.28M
Operating Income
-31.81M-32.91M-50.68M-94.09M-118.26M
Interest Income/Expense
3.53M3.39M5.37M-6.98M-10.86M
Other Income/Expense
N/A142.00K-413.00K-490.00K-600.00K
Non Recurring Items
149.00K-63.00K781.00K-20.78M-104.74M
Income Before Taxes
-28.12M-29.44M-44.95M-122.34M-234.46M
Income Tax
N/A-525.00K118.00K-200.00K-240.00K
Net Income
463.00K500.00K12.88M-117.93M-205.71M
EBITDA
-30.77M-31.79M-46.34M-85.64M-108.35M
 
Per Share Data
EPS Diluted Total Ops
0.150.164.27-4.82-12.80
Non GAAP EPS
N/AN/A12.92N/AN/A
 
Statistics
Gross Profit Margin
N/AN/AN/A38.55%43.67%
Profit Margin
94.11%124.69%2003.42%-3552.11%-4198.16%
Operating Profit Margin
-6464.63%-8207.48%-7881.65%-2834.04%-2413.47%

All data in CAD

Charts